Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - glucose - solution for infusion - 10 %w/v

Malta - English - Medicines Authority

fresenius medical care deutschland gmbh d-61346 bad homburg, germany - calcium, glucose - solution for peritoneal dialysis - calcium 1.25 mmol/l glucose 4.25 % (w/v) - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

fresenius medical care deutschland gmbh d-61346 bad homburg, germany - calcium, glucose - solution for peritoneal dialysis - calcium 1.75 mmol/l glucose 4.25 % (w/v) - blood substitutes and perfusion solutions

United States - English - NLM (National Library of Medicine)

rebel distributors corp - quetiapine fumarate (unii: 2s3pl1b6uj) (quetiapine - unii:bgl0jsy5si) - quetiapine fumarate 25 mg - seroquel is indicated for the treatment of schizophrenia. the efficacy of seroquel in schizophrenia was established in three 6-week trials in adults and one 6–week trial in adolescents (13–17 years). the effectiveness of seroquel for the maintenance treatment of schizophrenia has not been systematically evaluated in controlled clinical trials [see clinical studies (14.1)] seroquel is indicated for the acute treatment of manic episodes associated with bipolar i disorder, both as monotherapy and as an adjunct to lithium or divalproex. efficacy was established in two 12-week monotherapy trials in adults, in one 3-week adjunctive trial in adults, and in one 3-week monotherapy trial in pediatric patients (10-17 years) [see clinical studies (14.2)]. seroquel is indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder. efficacy was established in two 8-week monotherapy trials in adult patients with bipolar i and bipolar ii disorder [see clinical studies (14.2)]. sero

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - sodium (s)-lactate, quantity: 7.85 g/l - solution, irrigation - excipient ingredients: water for injections; sodium bicarbonate - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - sodium (s)-lactate, quantity: 7.85 g/l - solution, irrigation - excipient ingredients: water for injections; sodium bicarbonate - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - sodium (s)-lactate, quantity: 7.85 g/l - solution, irrigation - excipient ingredients: water for injections; sodium bicarbonate - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - sodium (s)-lactate, quantity: 7.85 g/l - solution, irrigation - excipient ingredients: water for injections; sodium bicarbonate - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - promethazine hydrochloride, is useful orally for. perennial and seasonal allergic rhinitis. vasomotor rhinitis. allergic conjunctivitis due to inhalant allergens and foods. mild, uncomplicated allergic skin manifestations of urticaria and angioedema. amelioration of allergic reactions to blood or plasma. dermographism. anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled. preoperative, postoperative, or obstetric sedation. prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. therapy adjunctive to meperidine or other analgesics for control of post-operative pain. sedation in both children and adults, as well as relief of apprehension and production of light sleep from which the patient can be easily aroused. active and prophylactic treatment of motion sickness. antiemetic therapy in postoperative patients. promethazine hydrochloride tablets, usp are contraindicated for use

United States - English - NLM (National Library of Medicine)

snap medical industries - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - adrenalin ® is available as a single-use 1 ml vial and a multiple-use 30 ml vial for intramuscular and subcutaneous use. emergency treatment of allergic reactions (type i), including anaphylaxis, which may result from allergic reactions to insect stings, biting insects, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. the signs and symptoms associated with anaphylaxis include flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with hypotension, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, airway swelling, laryngospasm, bronchospasm, pruritus, urticaria or angioedema, swelling of the eyelids, lips, and tongue. none. teratogenic effects: pregnancy category c. there are no adequate and well-controlled studies in pregnant women. epinephrine should be used during pregnancy only if the potential benefit justifies the potential risk to